CVNA
Carvana Co.
CVNA has the edge over LCID overall, supported by stronger valuation and stronger modeled upside.
LCID
Lucid Group, Inc.
LCID's outlook is improving, though it still trails on the overall score.
CVNA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Weak |
CVNA's revenue, profitability and cash flow are currently healthy, but its balance sheet is weak.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CVNA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 34x | $70.84 | — |
| Forward | 35x | $70.84 | — |
| Cheap | 36x | $75.86 | +7.1% |
| Fair | 83x | $173 | +144% |
| Expensive | 113x | $235 | +231% |
Historical ranges are pointers, not guarantees.
CVNA's PE is in its cheap range at 34x. On analysts' estimates for next year's earnings, today's price would be 35x.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
CVNA Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for CVNA, with profitability holding steady. However, they disagree widely on these estimates.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CVNA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.05 | -1.4% |
| Q3 2026 | $2.08 | +136% |
| Q2 2026 | $1.89 | +136% |
| Q1 2026 | $1.73 | +204% |
| Q4 2025 | $1.69 | +428% |
| Q3 2023 | -$1.22 | +$0.57 |
| Q2 2023 | -$2.51 | -$1.18 |
| Q1 2023 | -$2.87 | -$2.06 |
| Q4 2022 | -$3.15 | -$2.82 |
CVNA has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
CVNA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $8B | +42% |
| Q2 2026 | $7.4B | +52% |
| Q1 2026 | $6.4B | +52% |
| Q4 2025 | $5.6B | +58% |
| Q3 2025 | $5.6B | +55% |
| Q2 2025 | $4.8B | +42% |
| Q1 2025 | $4.2B | +38% |
| Q4 2024 | $3.5B | +46% |
CVNA has the edge over LCID on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.9% | -0.9 points |
| Q2 2026 | 9.2% | -1.4 points |
| Q1 2026 | 9% | -0.3 points |
| Q4 2025 | 7.6% | +0.2 points |
| Q3 2025 | 9.8% | +0.5 points |
| Q2 2025 | 11% | +3 points |
| Q1 2025 | 9.3% | +4.9 points |
| Q4 2024 | 7.3% | N/A |
CVNA has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID's revenue has grown year over year for 11 quarters in a row: $350M last quarter, up 4.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
CVNA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $491M | +60% |
| Q2 2026 | $187M | +$189M |
| Q1 2026 | $56M | -73% |
| Q4 2025 | $379M | +953% |
| Q3 2025 | $307M | -18% |
| Q2 2025 | -$2M | -101% |
| Q1 2025 | $205M | +147% |
| Q4 2024 | $36M | +$293M |
CVNA has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
CVNA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2021 | 186.0x | High |
| Q2 2021 | 128.9x | High |
CVNA's net debt is more than 20 years of its operating earnings (EBITDA).
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CVNA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.9 | Neutral |
| Stochastic | 67.9 | Neutral |
CVNA's weekly RSI is 53 (neutral) and its Stochastic is 68 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
CVNA PE vs Consumer Cyclical Sector
| Metric | CVNA | Sector median | Relative |
|---|---|---|---|
| PE | 34x | 18x | 89% above |
| PE % | 8 | 47 | 39 pts below |
CVNA is trading at 34x earnings, a 89% premium to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
CVNA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $65.2 | 8.6% above |
| 20 week MA | $67.3 | 5.3% above |
| 50 week MA | $71.3 | 0.7% below |
| 100 week MA | $64.7 | 9.5% above |
| 200 week MA | $40.2 | 76% above |
CVNA has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
CVNA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $19.6 | $54.9 | +181% |
| 2021 | $54.9 | $48.2 | -12% |
| 2022 | $48.2 | $0.81 | -98% |
| 2023 | $0.81 | $10.6 | +1207% |
| 2024 | $10.6 | $43.0 | +306% |
| 2025 | $43.0 | $87.7 | +104% |
| 2026 YTD | $87.7 | $70.8 | -19% |
CVNA has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.